ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Almanac 2012: cardiovascular risk scores. The journals present selected research that has driven recent advances in clinical cardiology [Anatol J Cardiol]
Anatol J Cardiol. 2013; 13(2): 195-201 | DOI: 10.5152/akd.2013.063

Almanac 2012: cardiovascular risk scores. The journals present selected research that has driven recent advances in clinical cardiology

Jill P. Pell1
Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ-UK

 

Global risk scores use individual level information on non-modifiable risk factors (such as age, sex, ethnicity and family history) and modifiable risk factors (such as smoking status and blood pressure) to predict an individual's absolute risk of an adverse event over a specified period of time in the future. Cardiovascular risk scores have two major uses in practice. First, they can be used to dichotomise people into a group whose baseline risk, and therefore potential absolute benefit, is sufficiently high to justify the costs and risks associated with an intervention (whether treatment or prevention) and a group with a lower absolute risk to whom the intervention is usually denied. Second, they can be used to assess the effectiveness of an intervention (such as smoking cessation or antihypertensive treatment) at reducing an individual's risk of future adverse events. In this context, they can be helpful in informing patients, motivating them to change their lifestyle, and reinforcing the importance of continued compliance.


Jill P. Pell. Almanac 2012: cardiovascular risk scores. The journals present selected research that has driven recent advances in clinical cardiology. Anatol J Cardiol. 2013; 13(2): 195-201
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.